Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
To compare intravenous Tranexamic Acid (TXA) versus normal saline placebo to determine
whether or not TXA administration reduces blood loss, decrease in hemoglobin, and rate of
transfusions following anatomic and reverse total shoulder arthroplasty (TSA) surgeries.